Panocka et al, Derwent Drug File Abstracts, abstract no. 1995-39814.* |
Ng et al, Medline Abstracts, abstract no. 95203333, 1994.* |
Dyr et al, Biological Abstracts, abstract no. 1993:323964.* |
Archer et al, Derwent Drug File Abstracts, abstract no. 1996-21249.* |
Caine et al, Derwent Drug File Abstracts, abstract no. 1994-38611.* |
Guse et al, Derwent Drug File Abstracts, abstract no. 1993-19338.* |
Cervo L., et al., Brain Research 673:2 pp. 242-250 (Mar. 6, 1995). |
Bednar, et al., American J. of Physiology 269:4 pt. 2 R896-902 (Oct., 1995). |
Cervo, et al., Brain Research 731:31-38 (1996). |
Nielsen, et al., European Journal of Pharmacology, 11:167-176 (1985). |
Corrigall, et al., Pharmacology Biochemistry and Behavior, 48:3 pp. 817-820 (1994). |
W. Dry, et al., “Effects of D1 and D2 Dopamine Receptor Agents on Ethanol Consumption in the High-Alcohol-Drinking (HAD) Line of Rats,” Alcohol, 10:207-212 (1993). |
Samochowiec et al., Pharmazie 50 pp. 815-818 (1995). |
I. Panocka et al., “Effects of the dopamine D1 receptor antagonist SCH 39166 on the ingestive behaviour of alcohol-preferring rats,” Psychopharmacology 120:227-235 (1995). |
Gordon YK. Ng, et al., “Dopamine receptor agonist reduces ethanol self-administration in the ethanol-preferring C57BL/6J inbred mouse,” European Journal of Pharmacology, Section 269 pp. 365-374 (1994). |
Sydney Archer, et al., Suppression of Morphine and cocaine Self-Administration in Rats by Mixed Mu Antagonist-Kappa Agonist (N-CBM-TAMO) and a Long-Acting Selective D1 Antagonist (AS0300), Bioorganic & Medicinal Chemistry Letters 6:10 pp. 1139-1144 (1996). |
S. Barak Caine, et al., “Effects of Dopamine D-1 and D-2 Antagonists on Cocaine Self-Administration Under Different Schedules of Reinforcement in the Rat,” The Journal of Pharmacology and Experimental Therapeutics, 270:1 pp. 209-218, 1994. |
Paul A. Guse, et al., “Attentuation of Arrhythmogenic Effects of Cocaine by a Dopaminergic Antagonist Schering 39166,” JACC 21:2 Feb. 1993, Abstract. |